Validation of real-time RT-PCR for detection of SARS-CoV-2 in the early stages of the COVID-19 outbreak in the Republic of Korea.

Yoon-Seok Chung, Nam-Joo Lee, Sang Hee Woo, Jeong-Min Kim, Heui Man Kim, Hye Jun Jo, Ye Eun Park, Myung-Guk Han
Author Information
  1. Yoon-Seok Chung: Division of Infectious Disease Diagnosis Control, Honam Regional Centers for Disease Control and Prevention, Korea Diseases Control and Prevention Agency, Gwangju-si, 61947, Republic of Korea.
  2. Nam-Joo Lee: Division of Emerging Infectious Diseases, Bureau of Infectious Disease Diagnosis Control, Korea Diseases Control and Prevention Agency, Cheongju-si, 28159, Republic of Korea.
  3. Sang Hee Woo: Division of Emerging Infectious Diseases, Bureau of Infectious Disease Diagnosis Control, Korea Diseases Control and Prevention Agency, Cheongju-si, 28159, Republic of Korea.
  4. Jeong-Min Kim: Division of Emerging Infectious Diseases, Bureau of Infectious Disease Diagnosis Control, Korea Diseases Control and Prevention Agency, Cheongju-si, 28159, Republic of Korea.
  5. Heui Man Kim: Division of Emerging Infectious Diseases, Bureau of Infectious Disease Diagnosis Control, Korea Diseases Control and Prevention Agency, Cheongju-si, 28159, Republic of Korea.
  6. Hye Jun Jo: Division of Emerging Infectious Diseases, Bureau of Infectious Disease Diagnosis Control, Korea Diseases Control and Prevention Agency, Cheongju-si, 28159, Republic of Korea.
  7. Ye Eun Park: Division of Laboratory Diagnosis Management, Bureau of Infectious Disease Diagnosis Control, Korea Diseases Control and Prevention Agency, Cheongju-si, 28159, Republic of Korea.
  8. Myung-Guk Han: Division of Viral Diseases, Bureau of Infectious Disease Diagnosis Control, Korea Diseases Control and Prevention Agency, 187 Osongsaengmyeong2-ro, Osong-eup, Heungdeok-gu, Cheongju-si, 28159, Republic of Korea. mghan@korea.kr.

Abstract

A real-time reverse transcription polymerase chain reaction (RT-qPCR) assay that does not require Emergency Use Authorization (EUA) reagents was tested and validated for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the early stages of the outbreak of coronavirus disease 2019 (COVID-19) in the Republic of Korea. Early diagnosis of COVID-19 enables timely treatment and the implementation of public health measures. We validated the sensitivity, specificity, precision, linearity, accuracy, and robustness of the RT-qPCR assay for SARS-CoV-2 detection and compared its performance with that of several EUA-approved kits. Our RT-qPCR assay was highly specific for SARS-CoV-2 as demonstrated by not amplifying 13 other viruses that cause respiratory diseases. The assay showed high linearity using a viral isolate from a patient with known COVID-19 as well as plasmids containing target SARS-CoV-2 genes as templates. The assay showed good repeatability and reproducibility with a coefficient of variation of 3%, and a SARS-CoV-2 limit of detection of 1 PFU/mL. The RT-qPCR-based assay is highly effective and can facilitate the early diagnosis of COVID-19 without the use of EUA-approved kits or reagents in the Republic of Korea.

References

  1. Lancet. 2020 Feb 22;395(10224):565-574 [PMID: 32007145]
  2. J Clin Microbiol. 2020 Apr 23;58(5): [PMID: 32132196]
  3. J Korean Med Sci. 2020 Feb 24;35(7):e86 [PMID: 32080991]
  4. Heliyon. 2020 Jul 07;6(7):e04405 [PMID: 32665985]
  5. Clin Chim Acta. 2020 Aug;507:248-249 [PMID: 32387093]
  6. J Clin Virol. 2020 Jul;128:104433 [PMID: 32405254]
  7. Emerg Microbes Infect. 2020 Dec;9(1):221-236 [PMID: 31987001]
  8. Osong Public Health Res Perspect. 2020 Jun;11(3):140-145 [PMID: 32528820]
  9. Osong Public Health Res Perspect. 2020 Feb;11(1):3-7 [PMID: 32149036]
  10. N Engl J Med. 2020 Feb 20;382(8):727-733 [PMID: 31978945]
  11. Ann Lab Med. 2020 Nov;40(6):490-492 [PMID: 32539306]
  12. Euro Surveill. 2020 May;25(21): [PMID: 32489175]
  13. Emerg Microbes Infect. 2020 Dec;9(1):1393-1396 [PMID: 32552549]
  14. Euro Surveill. 2020 May;25(21): [PMID: 32489177]

Grants

  1. [grant number 4800-4837-301]/This work was supported by Korea Centers for Disease Control and Prevention .
  2. [grant number 4800-4837-301]/This work was supported by Korea Centers for Disease Control and Prevention .
  3. [grant number 4800-4837-301]/This work was supported by Korea Centers for Disease Control and Prevention .
  4. [grant number 4800-4837-301]/This work was supported by Korea Centers for Disease Control and Prevention .
  5. [grant number 4800-4837-301]/This work was supported by Korea Centers for Disease Control and Prevention .
  6. [grant number 4800-4837-301]/This work was supported by Korea Centers for Disease Control and Prevention .
  7. [grant number 4800-4837-301]/This work was supported by Korea Centers for Disease Control and Prevention .
  8. [grant number 4800-4837-301]/This work was supported by Korea Centers for Disease Control and Prevention .

MeSH Term

Animals
COVID-19
COVID-19 Nucleic Acid Testing
Chlorocebus aethiops
Humans
Limit of Detection
Real-Time Polymerase Chain Reaction
Reproducibility of Results
Republic of Korea
Reverse Transcriptase Polymerase Chain Reaction
Vero Cells

Word Cloud

Created with Highcharts 10.0.0assaySARS-CoV-2COVID-19detectionRT-qPCRearlyRepublicKoreareal-timereagentsvalidatedrespiratorycoronavirusstagesoutbreakdiagnosislinearityEUA-approvedkitshighlyshowedreversetranscriptionpolymerasechainreactionrequireEmergencyUseAuthorizationEUAtestedsevereacutesyndrome2disease2019Earlyenablestimelytreatmentimplementationpublichealthmeasuressensitivityspecificityprecisionaccuracyrobustnesscomparedperformanceseveralspecificdemonstratedamplifying13virusescausediseaseshighusingviralisolatepatientknownwellplasmidscontainingtargetgenestemplatesgoodrepeatabilityreproducibilitycoefficientvariation3%limit1PFU/mLRT-qPCR-basedeffectivecanfacilitatewithoutuseValidationRT-PCR

Similar Articles

Cited By